Literature DB >> 10210877

Neurological complications to vaccination against Japanese encephalitis.

.   

Abstract

Japanese encephalitis (JE) vaccine has been used for childhood immunization programmes in Asia since the 1960s. Also, travellers from other parts of the world have been vaccinated before travelling to Asian countries. Some JE vaccines are produced from infected mouse brains and contain small amounts of myelin basic protein. Neurological side effects in larger vaccine trials in Asia have been reported in 1-2.3 per million vaccinees. Statens Serum Institut is the only distributor of JE vaccine in Denmark, delivering 384 000 doses from 1983-96. In 1996, evaluation of initial symptoms and findings in 10 adult travellers from Denmark, who developed moderate-severe neurological symptoms within a few weeks of JE vaccination, was performed as well as follow-up magnetic resonance imaging (MRI) and clinical neurological examination. Three patients initially had symptoms varying from severe encephalitis-like illness to paraesthesia, double vision or parkinsonian gait disturbance. MRI showed severe atrophy of the corpus callosum with altered signal intensity indicating gliosis in one patient, another patient had several hyperintense spots located periventricularly in the white matter, while a third patient had spots with increased signals in the pons, the right substantia nigra and the occipital region. Acute disseminated encephalomyelitis (ADEM) is a possible explanation for these MRI changes, although multiple sclerosis is an alternative diagnosis in one or two of the patients. Another three patients had long-lasting headache, concentration difficulty or intellectual reduction. One man had afebrile convulsions, another gait instability and depression and one parkinsonism. A woman developed myelitis. If these findings are due to JE vaccination the frequency of neurological reactions to the vaccine is considerably higher than previously reported and in the future any minor neurological complaints occurring shortly after vaccination should lead to neurological examination and acute MRI scan should be considered. Copyright 1998 Lippincott Williams & Wilkins

Entities:  

Year:  1998        PMID: 10210877     DOI: 10.1046/j.1468-1331.1998.550479.x

Source DB:  PubMed          Journal:  Eur J Neurol        ISSN: 1351-5101            Impact factor:   6.089


  13 in total

1.  Crystal structure of the Japanese encephalitis virus envelope protein.

Authors:  Vincent C Luca; Jad AbiMansour; Christopher A Nelson; Daved H Fremont
Journal:  J Virol       Date:  2011-12-07       Impact factor: 5.103

Review 2.  Japanese viral encephalitis.

Authors:  S V Tiroumourougane; P Raghava; S Srinivasan
Journal:  Postgrad Med J       Date:  2002-04       Impact factor: 2.401

3.  Inhibition of Japanese encephalitis virus infection by flavivirus recombinant E protein domain III.

Authors:  Jingjing Fan; Yi Liu; Xuping Xie; Bo Zhang; Zhiming Yuan
Journal:  Virol Sin       Date:  2013-05-25       Impact factor: 4.327

4.  A single dose of vero cell-derived Japanese encephalitis (JE) vaccine (Ixiaro) effectively boosts immunity in travelers primed with mouse brain-derived JE vaccines.

Authors:  Elina O Erra; Helena Hervius Askling; Lars Rombo; Jukka Riutta; Sirkka Vene; Sutee Yoksan; Lars Lindquist; Sari H Pakkanen; Eili Huhtamo; Olli Vapalahti; Anu Kantele
Journal:  Clin Infect Dis       Date:  2012-06-13       Impact factor: 9.079

5.  Ecological niche modeling to estimate the distribution of Japanese encephalitis virus in Asia.

Authors:  Robin H Miller; Penny Masuoka; Terry A Klein; Heung-Chul Kim; Todd Somer; John Grieco
Journal:  PLoS Negl Trop Dis       Date:  2012-06-19

Review 6.  The Potential Use of Wolbachia-Based Mosquito Biocontrol Strategies for Japanese Encephalitis.

Authors:  Claire L Jeffries; Thomas Walker
Journal:  PLoS Negl Trop Dis       Date:  2015-06-18

7.  Anti-NMDA Receptor Encephalitis and Vaccination.

Authors:  Hsiuying Wang
Journal:  Int J Mol Sci       Date:  2017-01-18       Impact factor: 5.923

8.  Immunogenicity and safety of inactivated chromatographically purified Vero cell-derived Japanese encephalitis vaccine in Thai children.

Authors:  Pornthep Chanthavanich; Kriengsak Limkittikul; Chukiat Sirivichayakul; Watcharee Chokejindachai; Weerawan Hattasingh; Krisana Pengsaa; Surachai Surangsrirat; Termsang Srisuwannaporn; Benjawan Kaewma; Sutee Yoksan; Gao Jun; Bai Zhumu
Journal:  Hum Vaccin Immunother       Date:  2018-01-16       Impact factor: 3.452

Review 9.  Japanese encephalitis: the virus and vaccines.

Authors:  Sang-Im Yun; Young-Min Lee
Journal:  Hum Vaccin Immunother       Date:  2013-10-25       Impact factor: 3.452

Review 10.  Japanese Encephalitis: A Brief Review on Indian Perspectives.

Authors:  Reshma Kulkarni; Gajanan N Sapkal; Himanshu Kaushal; Devendra T Mourya
Journal:  Open Virol J       Date:  2018-08-31
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.